[go: up one dir, main page]

HK1217088A1 - 微泡在醫學疾病和病况的診斷、預後和治療中的用途 - Google Patents

微泡在醫學疾病和病况的診斷、預後和治療中的用途

Info

Publication number
HK1217088A1
HK1217088A1 HK16105052.6A HK16105052A HK1217088A1 HK 1217088 A1 HK1217088 A1 HK 1217088A1 HK 16105052 A HK16105052 A HK 16105052A HK 1217088 A1 HK1217088 A1 HK 1217088A1
Authority
HK
Hong Kong
Prior art keywords
microvesicles
prognosis
diagnosis
treatment
conditions
Prior art date
Application number
HK16105052.6A
Other languages
English (en)
Inventor
Wayne Comper
Aparna Ramachandran
Haoheng Yan
Leileata M Russo
Johan Karl Olov Skog
Original Assignee
Exosome Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exosome Diagnostics Inc filed Critical Exosome Diagnostics Inc
Publication of HK1217088A1 publication Critical patent/HK1217088A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK16105052.6A 2012-10-03 2016-05-04 微泡在醫學疾病和病况的診斷、預後和治療中的用途 HK1217088A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261709337P 2012-10-03 2012-10-03
PCT/US2013/063292 WO2014055775A1 (en) 2012-10-03 2013-10-03 Use of microvesicles in diagnosis, prognosis, and treatment of medical diseases and conditions

Publications (1)

Publication Number Publication Date
HK1217088A1 true HK1217088A1 (zh) 2016-12-23

Family

ID=50435439

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16105052.6A HK1217088A1 (zh) 2012-10-03 2016-05-04 微泡在醫學疾病和病况的診斷、預後和治療中的用途

Country Status (6)

Country Link
US (1) US20150252428A1 (zh)
EP (1) EP2903597B1 (zh)
CN (1) CN105025878A (zh)
CA (1) CA2887058C (zh)
HK (1) HK1217088A1 (zh)
WO (1) WO2014055775A1 (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2744589T3 (es) * 2011-05-11 2020-02-25 Exosome Diagnostics Inc Extracción de ácido nucleico de materiales biológicos heterogéneos
US11180812B2 (en) 2012-08-17 2021-11-23 Cornell University Use of DNA in circulating exosomes as a diagnostic marker for metastatic disease
WO2015153732A2 (en) * 2014-04-01 2015-10-08 Cornell University Use of double-stranded dna in exosomes: a novel biomarker in cancer detection
WO2016057702A2 (en) 2014-10-07 2016-04-14 Cornell University Methods for prognosing and preventing metastatic liver disease
AU2015339137A1 (en) 2014-10-31 2017-05-25 Beth Israel Deaconess Medical Center Methods of detecting BRAF in cancer
US11971402B2 (en) 2015-04-24 2024-04-30 Cornell University Methods and reagents for determination and treatment of organotropic metastasis
US10252145B2 (en) 2016-05-02 2019-04-09 Bao Tran Smart device
CN110199019B (zh) 2016-05-02 2024-09-10 Encodia有限公司 采用核酸编码的大分子分析
CN110291089B (zh) 2017-01-17 2022-05-27 海帕瑞吉尼克斯股份有限公司 用于促进肝再生或者减少或预防肝细胞死亡的蛋白激酶抑制剂
US10381105B1 (en) 2017-01-24 2019-08-13 Bao Personalized beauty system
US10052026B1 (en) 2017-03-06 2018-08-21 Bao Tran Smart mirror
CN111133106A (zh) 2017-07-12 2020-05-08 外来体诊断公司 用于分离和富集生物流体来源的细胞外囊泡的方法及其使用方法
MX2020004559A (es) 2017-10-31 2020-10-05 Encodia Inc Kits para análisis utilizando codificación y/o etiqueta de ácido nucleico.
WO2019236123A1 (en) * 2018-06-04 2019-12-12 Memorial Sloan Kettering Cancer Center Methods of detecting cancer via assessment of extracellular vesicle- mediated horizontal transfer of dna: rna hybrids
AU2020233286B2 (en) 2019-03-01 2022-10-20 Mercy Bioanalytics, Inc. Systems, compositions, and methods for target entity detection
EP3963070A4 (en) 2019-04-30 2023-02-22 Encodia, Inc. METHODS OF PREPARATION OF ANALYTES AND RELATED KITS
CN110585433A (zh) * 2019-09-27 2019-12-20 青岛大学 Braf-v600e的抑制剂的应用及用于治疗甲状腺癌的药物
CN114981298B (zh) 2019-12-12 2024-08-20 听治疗有限责任公司 用于预防和治疗听力损失的组合物和方法

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639611A (en) 1988-12-12 1997-06-17 City Of Hope Allele specific polymerase chain reaction
US5219727A (en) 1989-08-21 1993-06-15 Hoffmann-Laroche Inc. Quantitation of nucleic acids using the polymerase chain reaction
US5840867A (en) 1991-02-21 1998-11-24 Gilead Sciences, Inc. Aptamer analogs specific for biomolecules
AU645915B2 (en) 1991-07-23 1994-01-27 F. Hoffmann-La Roche Ag Improvements in the in situ PCR
US5582981A (en) 1991-08-14 1996-12-10 Gilead Sciences, Inc. Method for identifying an oligonucleotide aptamer specific for a target
US5605798A (en) 1993-01-07 1997-02-25 Sequenom, Inc. DNA diagnostic based on mass spectrometry
US5639606A (en) 1993-04-06 1997-06-17 The University Of Rochester Method for quantitative measurement of gene expression using multiplex competitive reverse transcriptase-polymerase chain reaction
US5547859A (en) 1993-08-02 1996-08-20 Goodman; Myron F. Chain-terminating nucleotides for DNA sequencing methods
US5556773A (en) 1993-08-06 1996-09-17 Yourno; Joseph Method and apparatus for nested polymerase chain reaction (PCR) with single closed reaction tubes
US20030129589A1 (en) 1996-11-06 2003-07-10 Hubert Koster Dna diagnostics based on mass spectrometry
EP0985148A4 (en) 1997-05-28 2004-03-10 Inst Medical W & E Hall DIAGNOSIS OF NUCLEIC ACIDS BY MASS SPECTROMETRY, MASS SEPARATION AND BASE-SPECIFIC CLEAVING
US6004755A (en) 1998-04-07 1999-12-21 Incyte Pharmaceuticals, Inc. Quantitative microarray hybridizaton assays
WO2000004194A1 (en) 1998-07-20 2000-01-27 Variagenics, Inc. Gene sequence variances with utility in determining the treatment of disease
FR2788780B1 (fr) 1999-01-27 2001-03-30 Ap Cells Inc Procede de preparation de vesicules membranaires
GB9927320D0 (en) 1999-11-18 2000-01-12 Chiron Spa Exosome separation
AU2001230668A1 (en) 2000-01-28 2001-08-07 Mip Technologies Ab Functional monomers for molecular recognition and catalysis
US6812023B1 (en) 2000-04-27 2004-11-02 Anosys, Inc. Methods of producing membrane vesicles
US6913879B1 (en) 2000-07-10 2005-07-05 Telechem International Inc. Microarray method of genotyping multiple samples at multiple LOCI
US6525154B1 (en) 2000-07-20 2003-02-25 The Regents Of The University Of California Molecular imprinting for the recognition of peptides in aqueous solution
US6696271B2 (en) 2001-08-23 2004-02-24 The Regents Of The University Of California Frozen tissue microarray technology for analysis of RNA, DNA, and proteins
WO2003023065A1 (en) 2001-09-06 2003-03-20 Syngenta Participations Ag Dna methylation patterns
US20030162190A1 (en) 2001-11-15 2003-08-28 Gorenstein David G. Phosphoromonothioate and phosphorodithioate oligonucleotide aptamer chip for functional proteomics
ES2431944T3 (es) 2002-06-26 2013-11-28 Cold Spring Harbor Laboratory Métodos para determinar los perfiles de metilación
CA2497288A1 (en) 2002-09-02 2004-03-11 Pamgene B.V. Novel integrated microarray analysis
US7141371B2 (en) 2002-09-06 2006-11-28 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon Methods for detecting and localizing DNA mutations by microarray
US7384589B2 (en) 2003-08-01 2008-06-10 Lawrence Livermore National Security, Llc Nanoscale molecularly imprinted polymers and method thereof
JP2008501336A (ja) * 2004-06-02 2008-01-24 ソースフアーム・インコーポレイテツド Rnaを含有する微小胞およびそのための方法
US20080187923A1 (en) 2005-04-15 2008-08-07 Cedars-Sinai Medical Center Flow-Cytometric Heteroduplex Analysis for Detection of Genetic Alterations
MX2009002936A (es) * 2006-09-19 2009-04-01 Novartis Ag Biomarcadores de la modulacion de objetivo, eficacia, diagnostico, y/o pronostico para los inhibidores de raf.
EP3239305A3 (en) * 2008-02-01 2017-11-29 The General Hospital Corporation Use of microvesicles in diagnosis and prognosis of medical diseases and conditions
US20120059021A1 (en) * 2008-11-11 2012-03-08 University Of Washington Compositions and methods for treating cancer and methods for predicting a response to such treatments
CN102498397B (zh) * 2009-07-16 2016-04-06 总医院有限公司 核酸分析
WO2011031892A1 (en) * 2009-09-09 2011-03-17 The General Hospital Corporation Use of microvesicles in analyzing kras mutations
WO2012012693A2 (en) * 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
CN103782174A (zh) * 2011-06-07 2014-05-07 卡里斯生命科学卢森堡控股有限责任公司 用于癌症的循环生物标志物
EP2748335B1 (en) * 2011-08-22 2018-10-03 Exosome Diagnostics, Inc. Urine biomarkers

Also Published As

Publication number Publication date
CA2887058A1 (en) 2014-04-10
WO2014055775A1 (en) 2014-04-10
EP2903597A1 (en) 2015-08-12
CA2887058C (en) 2022-02-22
US20150252428A1 (en) 2015-09-10
EP2903597A4 (en) 2016-07-06
CN105025878A (zh) 2015-11-04
EP2903597B1 (en) 2019-12-18

Similar Documents

Publication Publication Date Title
HK1217088A1 (zh) 微泡在醫學疾病和病况的診斷、預後和治療中的用途
EP2875158A4 (en) USE OF MICROVESICLES IN THE DIAGNOSIS, FORECAST AND TREATMENT OF DISEASES AND MEDICAL SUDDEN
IL265774B (en) Diagnosis, prevention and treatment of joint diseases
IL276300A (en) GRPR antagonists for the detection, diagnosis and treatment of GRPR-positive cancer
HRP20190116T1 (hr) Slit-robo signaliziranje, namijenjeno dijagnosticiranju i liječenju bubrežne bolesti
HK1213192A1 (zh) 用於在人類受試者中治療眼部疾病的方法和裝置
HK1212273A1 (zh) 治療和診斷黑素瘤
HK1158705A1 (zh) 微泡在醫學疾病和病況的診斷、預後以及治療中的用途
EP2811897A4 (en) MEDICAL TERMINAL AND APPLICATION METHOD
SG10201604167XA (en) Blood treatment systems and methods
EP2893030A4 (en) DIAGNOSIS AND TREATMENT OF INVASIVE ASPERGILLOSIS
PL2683826T3 (pl) Zastosowanie aptamerów w terapii i/lub diagnostyce chorób autoimmunologicznych
HK1215000A1 (zh) 結腸癌的治療和診斷
EP2888370A4 (en) DIAGNOSIS, FORECASTING AND TREATMENT PROCEDURES
ZA201502288B (en) Ciclesonide for treatment of airway disease in horses
EP2670438A4 (en) SELECTION AND TREATMENT OF PATIENTS
EP2943593A4 (en) DIAGNOSIS AND TREATMENT OF VIRUS DISEASES
EP2588866A4 (en) DIAGNOSIS AND TREATMENT OF BRAIN TUMORS
HK1209073A1 (zh) 刺激劑及其在處理皮膚中的應用
GB201214541D0 (en) Skin treatment formulation, and use thereof